Lower GI imaging with a tethered camera capsule

Pilot Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule

NA · Massachusetts General Hospital · NCT07219537

This test tries a small camera capsule on a string that takes pictures of the lower gut without sedation for adults who are healthy or who have Lynch syndrome, Crohn's disease, or other inflammatory bowel diseases.

Quick facts

PhaseNA
Study typeInterventional
Enrollment30 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorMassachusetts General Hospital (other)
Locations1 site (Boston, Massachusetts)
Trial IDNCT07219537 on ClinicalTrials.gov

What this trial studies

Investigators will insert a vitamin-sized tethered capsule into the lower gastrointestinal tract and advance it upward using a motorized slow spiral motion while it records optical coherence tomography (OCT) images in real time. The capsule remains attached to a string so it can be controlled and retrieved without sedation. Participants follow a standard bowel preparation before the procedure to clear the colon for imaging. The approach is being studied as a feasibility tool to capture structural images of the lower colon and rectum without traditional endoscopy.

Who should consider this trial

Good fit: Adults aged 18 to 75 who can give consent, tolerate bowel prep, and are either healthy or have a confirmed diagnosis of Lynch syndrome or report no known lower GI disease (or had a normal colonoscopy within the past 24 months) are ideal candidates.

Not a fit: People with prior colorectal or anorectal surgery, colonic strictures, diverticulosis/diverticulitis, colorectal cancer, bleeding disorders, use of most anticoagulants, pregnancy, or contraindications to bowel prep are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, this could offer a lower-cost, sedation-free way to image the lower colon and rectum, making screening or surveillance more comfortable and accessible.

How similar studies have performed: Tethered capsule imaging approaches have shown feasibility in the esophagus, but retrograde OCT imaging of the lower GI tract is relatively novel and remains at the feasibility stage.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Are 18 years of age or older.
* Are healthy or with a confirmed diagnosis of Lynch Syndrome
* Are capable of giving informed consent.
* Are able to follow bowel prep instructions
* Had a colonoscopy 0-24 months prior that did not show any abnormalities or individuals who report no gastrointestinal symptoms and no knowledge of any lower GI tract disease or abnormality and volunteer through Rally.

Exclusion Criteria:

* Who are over 75 years of age or older
* With a history or current diagnosis of colonic and/or anal strictures
* With a current diagnosis of any bleeding disorders
* Who currently use drugs that interfere with coagulation (excluding low-dose aspirin)
* With a history or current diagnosis of colorectal cancer
* With a history or current diagnosis of diverticulosis or diverticulitis
* With any prior anorectal, colorectal, or colonic surgery
* With a history of volvulus or torsion
* Who are pregnant
* With contraindications to bowel prep or colonoscopy
* With severe acute inflammatory bowel disease
* With large hemorrhoids or hemorrhoidal bleeding or banding

Where this trial is running

Boston, Massachusetts

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Lynch Syndrome, Crohn Disease, Inflammatory Bowel Diseases, Healthy

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.